The semi-solid drug category is comprised of creams, gels, ointments, suppositories, and other special topical dosage forms. Semi-solid drug formulations share many common attributes which include consistency, dosage uniformity, preservatives, the route of administration and their formulation basis.
This report contains market size and forecasts of Semi-Solid Formulations Drug Delivery in Global, including the following market information:
- Global Semi-Solid Formulations Drug Delivery Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Semi-Solid Formulations Drug Delivery market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Creams Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Semi-Solid Formulations Drug Delivery include Glenmark Pharmaceuticals, Galderma, Johnson & Johnson Private, GlaxoSmithKline, Bausch Health Companies, Hisamitsu Pharmaceuticals, Cipla, Bayer and Viatris, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Semi-Solid Formulations Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Semi-Solid Formulations Drug Delivery Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Semi-Solid Formulations Drug Delivery Market Segment Percentages, by Type, 2021 (%)
- Creams
- Ointments
- Lotions
- Gel
- Pastes
Global Semi-Solid Formulations Drug Delivery Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Semi-Solid Formulations Drug Delivery Market Segment Percentages, by Application, 2021 (%)
- Home Care Settings
- Hospitals & Clinics
- Burn Centers
- Other Facilities
Global Semi-Solid Formulations Drug Delivery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Semi-Solid Formulations Drug Delivery Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Semi-Solid Formulations Drug Delivery revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Semi-Solid Formulations Drug Delivery revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Glenmark Pharmaceuticals
- Galderma
- Johnson & Johnson Private
- GlaxoSmithKline
- Bausch Health Companies
- Hisamitsu Pharmaceuticals
- Cipla
- Bayer
- Viatris
- 3M
- Merck & Co
- Crescita Therpeautics
- Novartis International
- Boehringer Ingelheim
- Pfizer
- Teva Pharmaceuticals
- Bristol Myers Squibb
- Lead Chemical
- Purdue Pharma
